Furthermore, a broad inhibitory activity towards tumor-involving protein signaling pathways, such as signal transducer and activator of transcription 3 (STAT3), Notch, nuclear factor κB (NF-κB), and Wnt/β-catenin, are reported in the past decade. This evidence concerns the gene STAT3 and neoplasm.